Unh, buy , sell or hold


Aime
UnitedHealth Group (UNH) appears to be a strong buy. Here's why:
- Financial Performance: UnitedHealth's financials are robust, with a net income of $6.26 billion and a diluted EPS of $6.51 as of Q3 20241. The company's revenue growth rate of 9.16% and net income growth rate of 3.64% indicate a healthy profitability trend2.
1/3
UNH Total Revenue YoY, Total Revenue
- Growth Prospects: The company's 3-year revenue CAGR is 13.67%, the net income CAGR is 14.25%, and the diluted EPS CAGR is 14.88%3. These figures suggest that UnitedHealth is not only growing but also maintaining a consistent growth rate, which is a positive sign for investors.
UNH Total Revenue (FY), Net Income (FY)...
- Technical Indicators: The technical indicators show a positive trend. The RSI is at 40.98, which is neither overbought nor oversold4. The MACD is -3.68, and the KDJ is 44.27, indicating a potential upward momentum4.
UNH Trend
- Analyst Ratings: The consensus among analysts is positive, with an average price target of $675, which is a 4.48% upside from the current price5. This suggests that analysts are optimistic about the stock's future performance.
UNH Average Price Target
- Dividend and Fund Flow: UnitedHealth has a dividend yield of 1.41%6, which is modest but provides an income stream for investors. The dividend growth duration is 14 years, and the dividend continuous duration is 19 years7, indicating a stable dividend history.
UNH Dividend Yield (TTM)
- Market Sentiment: The company has strong fundamentals, with more than 70% of companies having a lower mix of growth, profitability, debt, and visibility8. This suggests that UnitedHealth is relatively strong compared to its peers.
- Challenges and Risks: Despite the positive indicators, there are challenges such as Medicare coding intensity and acuity headwinds in the Medicaid sector9. These challenges could impact the company's performance, but they are not currently reflected in the financial data.
In conclusion, UnitedHealth Group shows strong financials, positive growth prospects, and a favorable technical outlook, supported by a positive analyst consensus. However, investors should consider the potential challenges and market conditions.
Source:
1.
UNH Revenue, Net Income, Diluted EPS
more
less
Continue this conversation 

Explore
Screener
Analysis
Learn